Thrombosis after septal closure device placement: A review of the current literature

Catheterization and Cardiovascular Interventions

Volumn 63, Issue 4, 2004, Pages 486-489

  Sherman, Jonathan M ^a   Hagler, Donald J ^a   Cetta, Frank ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Atrial septal defect; Device; Patent foramen ovale; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; WARFARIN;

ANTICOAGULATION; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; DEVICE; ECHOCARDIOGRAPHY; FIBRINOLYTIC THERAPY; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEMOPHILIA A; HUMAN; PATIENT MONITORING; REVIEW; THROMBOSIS; THROMBOSIS PREVENTION;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION; DEVICE REMOVAL; EQUIPMENT DESIGN; EUROPE; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTUM; HUMANS; MIDDLE AGED; THROMBOSIS; UNITED STATES;

EID: 9644303317     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20220     Document Type: Review

References (22)

1. Krumsdorf U, Keppeler P, Horvath K, Zadan E, Schrader R, Sievert H. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol 2001;14:49-55.
2. La Rosee K, Deutsch HJ, Schnabel P, Schneider CA, Burkhard-Meier C, Hopp HW. Thrombus formation after transcatheter closure of atrial septal defect. Am J Cardiol 1999;84:356-359.
3. Sievert H, Babic UU, Hausdorf G, Schneider M, Hopp HW, Pfeiffer D, Pfisterer M, Friedli B, Urban P, on behalf of ASDOS study group. Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial). Am J Cardiol 1998;82:1405-1413.
4. Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H, Scherer D, Schrader R, Spies H, Nowak B, Libmann-Jensen H. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol 2001;14:261-266.
5. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol 2004;43:302-309.
6. Acar P, Aggoun Y, Abdel-Massih T. Thrombus after transcatheter closure of ASD with an Amplatzer septal occluder assessed by three dimensional echocardiographic reconstruction. Heart 2002;88:52.
7. Bohm J, Bittigau K, Kohler F, Baumann G, Konertz W. Surgical removal of atrial septal defect occlusion system-devices. Eur J Cardio-Thorac Surg 1997;12:869-872.
8. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, Strasser RH. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
9. Cetta F, Arruda MJ, Graham LC. Large left atrial thrombus formation despite warfarin therapy after device closure of a patent foramen ovale. Catheter Cardiovasc Interv 2003;59:396-398.
10. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pome G, Bossone E, Frigiola A. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-1065.
11. Ende DJ, Chopra PS, Rao PS. Transcatheter closure of atrial septal defect or patent foramen ovale with buttoned device for prevention of recurrence of paradoxic embolism. Am J Cardiol 1996;78:233-236.
12. Fabricius AM, Krueger M, Falk V, Hanke M, Mohr FW. Floating thrombus on an ASD occluder device in a patient with hemophilia A. Thorac Cardiovasc Surg 2001;49:312-313.
13. Gastmann O, Werner GS, Babic UU, Figulla HR. Thrombus formation on transcatheter ASD occluder device in a patient with coagulation factor XII deficiency. Cathet Cardiovasc Diagn 1998;43:81-83.
14. Khatchatourov G, Kalangos A, Anwar A, Urban P, De Moerloose P, Friedli B, Faidutti B. Massive thromboembolism due to transcatheter ASD closure with ASDOS device. J Invas Cardiol 1999;11:743-745.
15. La Rosee K, Krause D, Becker M, Beuckelmann DJ, Deutsch HJ, Hopp HW. Katheterinterventioneller verschluss von vorhofseptumdefekten im erwachsenenalter. Dtsch Med Wochenschr 2001;126:1030-1036.
16. Nkomo VN, Theuma P, Maniu CV, Chandrasekaran K, Miller FA, Schaff HV, Petty GW, Miller TD. Patent foramen ovale transcatheter closure device thrombosis. Mayo Clin Proc 2001;76:1057-1061.
17. Rickers C, Hamm C, Stern H, Hofmann T, Franzen O, Schrader R, Sievert H, Schranz D, Michel-Behnke I, Vogt J, Kececioglu D, Sebening W, Eicken A, Meyer H, Matthies W, Kleber F, Hug J, Weil J. Percutaneous closure of secundum atrial septal defect with a new self centering device ("Angel Wings"). Heart 1998;80:517-521.
18. Rieber J, Schiele TM, Konig A, Limmert T, Theisen K, Stempfle HU, Klauss V. Large right atrial thrombus formation originating from a PFO occluder device. Clin Cardiol 2003;26:350.
19. Stangl V, Stangl K, Bohm J, Felix SB. Thrombus formation after catheter closure of an atrial septal defect with a clamshell device. Ann Thorac Surg 2000;69:1956.
20. Vanderheyden M, Willaert W, Claessens P, Branders I, Ex P, Vermeersch P. Thrombosis of a patent foramen ovale closure device: thrombolytic management. Catheter Cardiovasc Interv 2002;56:522-526.
21. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter clsoure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli. Ann Intern Med 2003;139:753-760.
22. Hung J, Landzberg MJ, Jenkins KJ, King MEE, Lock JE, Palacios IF, Lang P. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following trancatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.